DOI: 10.1055/s-00050348

Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Cortes J, Kim DW, Raffoux E, Martinelli G, Ritchie E, Roy L. et al.
Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase.

Leukemia 2008;
22: 2176-83

Bibliographische Angaben herunterladen

Aufrufen in:
Aufrufen in: